Yes, marketed by Alere Medical Pvt Ltd, which is an unlisted subsidiary owned by Abbott Laboratories, USA . LINK
Even if not marketed by listed entity, still it augments the brand value if this product picks up in popularity, which is good for the rest of the products.
Given that the earnings weren’t spectacular in the last 2-3 quarters but the stock was trading at 65 PE when it reached almost Rs 24000 against historical PE of around 42, this seems like a correction in line with the broader markets.
I believe the Abbott India business does not sell these products under the listed entity - it’s under the private business where consumer products like Ensure etc are sold. That is usually a negative for the stock but in this case it should be helpful!
Although will be interesting to monitor the stock if news flow continues on this.
But these products have high margins. And they could increase the ROCE and Free cash flow of the firm if they sold under the listed entity. I don’t know why abbott doing this. I guess these could be the reasons of Marcellus exiting this company.